AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy VolunteersRheumatoid Arthritis
- Interventions
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 21
- Registration Number
- NCT01355354
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT01354782
- Locations
- 🇨🇳
Nycomed Investigational Site, Beijing, China
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies
- First Posted Date
- 2011-05-16
- Last Posted Date
- 2016-04-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 39
- Registration Number
- NCT01353781
- Locations
- 🇯🇵
Research Site, Chuo-ku, Japan
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
Completed
- Conditions
- Hypercholesterolaemia
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2011-05-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 800
- Registration Number
- NCT01352897
- Locations
- 🇸🇬
Research Site, Singapore, Singapore
An Open Label Prostate Cancer Study in Japanese Patients
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2013-07-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 13
- Registration Number
- NCT01351688
- Locations
- 🇯🇵
Research Site, Sunto-gun, Shizuoka, Japan
Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers
Phase 1
Completed
- Conditions
- Drug Drug Interaction
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 22
- Registration Number
- NCT01350921
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6
- Registration Number
- NCT01348724
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 39
- Registration Number
- NCT01348139
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Alzheimer's DiseaseSafetyTolerabilityBlood ConcentrationHealthy Volunteers
- Interventions
- Drug: AZD3839 Placebo
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 72
- Registration Number
- NCT01348737
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
Phase 4
Completed
- Conditions
- Myocardial InfarctionSegment Elevation Myocardial Infarction (STEMI)
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-05-04
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1875
- Registration Number
- NCT01347580
- Locations
- 🇬🇧
Research Site, Sheffield, United Kingdom